吉藤 元

最終更新日時: 2019/06/03 20:59:31

印刷する

氏名(漢字/フリガナ/アルファベット表記)
吉藤 元/ヨシフジ ハジメ/Yoshifuji, Hajime
所属部署・職名(部局/所属/講座等/職名)
医学部附属病院/内科(免疫・膠原病内科)/助教
学内兼務
部局 所属 講座等 職名
医学研究科 医学研究科 医学専攻
連絡先住所
種別 住所(日本語) 住所(英語)
職場 〒606-8507 京都市左京区聖護院川原町54 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507 JAPAN
連絡先電話番号
種別 番号
職場 075-751-4380
所属学会(国内)
学会名(日本語) 学会名(英語)
日本内科学会 The Japanese Society of Internal Medicine
日本リウマチ学会 Japan College of Rheumatology
日本免疫学会 Japanese Society for Immunology
日本臨床免疫学会 Japan Society for Clinical Immunology
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士(医学) 京都大学
出身大学院・研究科等
大学名(日本語) 大学名(英語) 研究科名(日本語) 研究科名(英語) 専攻名(日本語) 専攻名(英語) 修了区分
京都大学 大学院医学研究科博士課程内科系専攻 修了
出身学校・専攻等
大学名(日本語) 大学名(英語) 学部名(日本語) 学部名(英語) 学科名(日本語) 学科名(英語) 卒業区分
京都大学 医学部医学科 卒業
使用言語
言語名
英語
researchmap URL
https://researchmap.jp/read0066267
研究分野(キーワード)
キーワード(日本語) キーワード(英語)
膠原病 Rheumatic diseases
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by <i>Zap70</i> Mutation. Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by <i>Zap70</i> Mutation. Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by <i>Zap70</i> Mutation. Journal of immunology (Baltimore, Md. : 1950), 202, 11, 3161-3172 Journal of immunology (Baltimore, Md. : 1950), 202, 11, 3161-3172 Journal of immunology (Baltimore, Md. : 1950), 202, 11, 3161-3172 2019/06 公開
Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis. Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis. Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis. Modern rheumatology, 1-21 Modern rheumatology, 1-21 Modern rheumatology, 1-21 2019/05 公開
Yoshifuji H Yoshifuji H Yoshifuji H Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. Modern rheumatology, 29, 2, 287-293 Modern rheumatology, 29, 2, 287-293 Modern rheumatology, 29, 2, 287-293 2019/03 公開
Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis. Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis. Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis. Modern rheumatology, 1-5 Modern rheumatology, 1-5 Modern rheumatology, 1-5 2019/02 公開
Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritis. Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritis. Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritis. Proceedings of the National Academy of Sciences of the United States of America, 115, 51, 13045-13050 Proceedings of the National Academy of Sciences of the United States of America, 115, 51, 13045-13050 Proceedings of the National Academy of Sciences of the United States of America, 115, 51, 13045-13050 2018/12 公開
Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Modern rheumatology, 28, 5, 838-844 Modern rheumatology, 28, 5, 838-844 Modern rheumatology, 28, 5, 838-844 2018/09 公開
Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Scientific reports, 8, 1, 10262 Scientific reports, 8, 1, 10262 Scientific reports, 8, 1, 10262 2018/07 公開
Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. Journal of gastroenterology, 53, 7, 845-853 Journal of gastroenterology, 53, 7, 845-853 Journal of gastroenterology, 53, 7, 845-853 2018/07 公開
Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice. Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice. Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice. Modern rheumatology, 28, 4, 626-636 Modern rheumatology, 28, 4, 626-636 Modern rheumatology, 28, 4, 626-636 2018/07 公開
Imura Y, Yukawa N, Handa T, Nakashima R, Murakami K, Yoshifuji H, Ohmura K, Ishii H, Nakata K, Mimori T Imura Y, Yukawa N, Handa T, Nakashima R, Murakami K, Yoshifuji H, Ohmura K, Ishii H, Nakata K, Mimori T Imura Y, Yukawa N, Handa T, Nakashima R, Murakami K, Yoshifuji H, Ohmura K, Ishii H, Nakata K, Mimori T Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. Modern rheumatology, 28, 4, 724-729 Modern rheumatology, 28, 4, 724-729 Modern rheumatology, 28, 4, 724-729 2018/07 公開
Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 31, 6, 890-899 Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 31, 6, 890-899 Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 31, 6, 890-899 2018/06 公開
Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, Salah A, Nakajima T, Kiso K, Yamada N, Haga H, Tsuruyama T Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, Salah A, Nakajima T, Kiso K, Yamada N, Haga H, Tsuruyama T Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, Salah A, Nakajima T, Kiso K, Yamada N, Haga H, Tsuruyama T Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes. Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes. Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes. Arthritis research & therapy, 20, 1, 13 Arthritis research & therapy, 20, 1, 13 Arthritis research & therapy, 20, 1, 13 2018/01 公開
Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. Arthritis research & therapy, 19, 1, 197 Arthritis research & therapy, 19, 1, 197 Arthritis research & therapy, 19, 1, 197 2017/09 公開
Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases. Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases. Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases. The Journal of rheumatology, 44, 9, 1384-1388 The Journal of rheumatology, 44, 9, 1384-1388 The Journal of rheumatology, 44, 9, 1384-1388 2017/09 公開
Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T Clinical Images: Chronic Nonbacterial Osteomyelitis. Clinical Images: Chronic Nonbacterial Osteomyelitis. Clinical Images: Chronic Nonbacterial Osteomyelitis. Arthritis & rheumatology (Hoboken, N.J.), 69, 8, 1660 Arthritis & rheumatology (Hoboken, N.J.), 69, 8, 1660 Arthritis & rheumatology (Hoboken, N.J.), 69, 8, 1660 2017/08 公開
Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. Scientific reports, 7, 1, 6911 Scientific reports, 7, 1, 6911 Scientific reports, 7, 1, 6911 2017/07 公開
Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. Rheumatology (Oxford, England), 56, 7, 1217-1226 Rheumatology (Oxford, England), 56, 7, 1217-1226 Rheumatology (Oxford, England), 56, 7, 1217-1226 2017/07 公開
Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosis. Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosis. Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosis. Annals of the rheumatic diseases, 76, 6, 1150-1158 Annals of the rheumatic diseases, 76, 6, 1150-1158 Annals of the rheumatic diseases, 76, 6, 1150-1158 2017/06 公開
Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. International journal of rheumatic diseases, 20, 6, 731-736 International journal of rheumatic diseases, 20, 6, 731-736 International journal of rheumatic diseases, 20, 6, 731-736 2017/06 公開
Mori M, Hashimoto M, Matsuo T, Fujii T, Furu M, Ito H, Yoshitomi H, Hirose J, Ito Y, Akizuki S, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Mimori T Mori M, Hashimoto M, Matsuo T, Fujii T, Furu M, Ito H, Yoshitomi H, Hirose J, Ito Y, Akizuki S, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Mimori T Mori M, Hashimoto M, Matsuo T, Fujii T, Furu M, Ito H, Yoshitomi H, Hirose J, Ito Y, Akizuki S, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Mimori T Cell-contact-dependent activation of CD4<sup>+</sup> T cells by adhesion molecules on synovial fibroblasts. Cell-contact-dependent activation of CD4<sup>+</sup> T cells by adhesion molecules on synovial fibroblasts. Cell-contact-dependent activation of CD4<sup>+</sup> T cells by adhesion molecules on synovial fibroblasts. Modern rheumatology, 27, 3, 448-456 Modern rheumatology, 27, 3, 448-456 Modern rheumatology, 27, 3, 448-456 2017/05 公開
Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. Journal of autoimmunity, 77, 116-122 Journal of autoimmunity, 77, 116-122 Journal of autoimmunity, 77, 116-122 2017/02 公開
Tsuji H, Yoshifuji H, Fujii T, Matsuo T, Nakashima R, Imura Y, Yukawa N, Ohmura K, Sumiyoshi S, Mimori T Tsuji H, Yoshifuji H, Fujii T, Matsuo T, Nakashima R, Imura Y, Yukawa N, Ohmura K, Sumiyoshi S, Mimori T Tsuji H, Yoshifuji H, Fujii T, Matsuo T, Nakashima R, Imura Y, Yukawa N, Ohmura K, Sumiyoshi S, Mimori T Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. Modern rheumatology, 27, 1, 155-161 Modern rheumatology, 27, 1, 155-161 Modern rheumatology, 27, 1, 155-161 2017/01 公開
Kiso K, Yoshifuji H, Oku T, Hikida M, Kitagori K, Hirayama Y, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A Kiso K, Yoshifuji H, Oku T, Hikida M, Kitagori K, Hirayama Y, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A Kiso K, Yoshifuji H, Oku T, Hikida M, Kitagori K, Hirayama Y, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients. Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients. Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients. PloS one, 12, 9, e0184738 PloS one, 12, 9, e0184738 PloS one, 12, 9, e0184738 2017 公開
Kitagori K, Yoshifuji H Kitagori K, Yoshifuji H Kitagori K, Yoshifuji H Osteopontin in systemic lupus erythematosus. Osteopontin in systemic lupus erythematosus. Osteopontin in systemic lupus erythematosus. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 40, 2, 118-123 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 40, 2, 118-123 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 40, 2, 118-123 2017 公開
Salah A, Yoshifuji H, Ito S, Kitagori K, Kiso K, Yamada N, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A Salah A, Yoshifuji H, Ito S, Kitagori K, Kiso K, Yamada N, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A Salah A, Yoshifuji H, Ito S, Kitagori K, Kiso K, Yamada N, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach. High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach. High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach. Pathology research international, 2017, 9312142 Pathology research international, 2017, 9312142 Pathology research international, 2017, 9312142 2017 公開
Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. Rheumatology (Oxford, England), 55, 9, 1686-1692 Rheumatology (Oxford, England), 55, 9, 1686-1692 Rheumatology (Oxford, England), 55, 9, 1686-1692 2016/09 公開
Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis. PloS one, 11, 12, e0167141 PloS one, 11, 12, e0167141 PloS one, 11, 12, e0167141 2016 公開
Yamakawa N, Oe K, Yukawa N, Murakami K, Nakashima R, Imura Y, Yoshifuji H, Ohmura K, Miura Y, Tomosugi N, Kawabata H, Takaori-Kondo A, Mimori T Yamakawa N, Oe K, Yukawa N, Murakami K, Nakashima R, Imura Y, Yoshifuji H, Ohmura K, Miura Y, Tomosugi N, Kawabata H, Takaori-Kondo A, Mimori T Yamakawa N, Oe K, Yukawa N, Murakami K, Nakashima R, Imura Y, Yoshifuji H, Ohmura K, Miura Y, Tomosugi N, Kawabata H, Takaori-Kondo A, Mimori T A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. Internal medicine (Tokyo, Japan), 55, 18, 2697-2701 Internal medicine (Tokyo, Japan), 55, 18, 2697-2701 Internal medicine (Tokyo, Japan), 55, 18, 2697-2701 2016 公開
Tsuji H, Ohmura K, Nakashima R, Hashimoto M, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Mimori T Tsuji H, Ohmura K, Nakashima R, Hashimoto M, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Mimori T Tsuji H, Ohmura K, Nakashima R, Hashimoto M, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Mimori T Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. Internal medicine (Tokyo, Japan), 55, 12, 1547-1552 Internal medicine (Tokyo, Japan), 55, 12, 1547-1552 Internal medicine (Tokyo, Japan), 55, 12, 1547-1552 2016 公開
Hiramatsu S, Ohmura K, Tsuji H, Kawabata H, Kitano T, Sogabe A, Hashimoto M, Murakami K, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Takaori-Kondo A, Mimori T Hiramatsu S, Ohmura K, Tsuji H, Kawabata H, Kitano T, Sogabe A, Hashimoto M, Murakami K, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Takaori-Kondo A, Mimori T Hiramatsu S, Ohmura K, Tsuji H, Kawabata H, Kitano T, Sogabe A, Hashimoto M, Murakami K, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Takaori-Kondo A, Mimori T Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 39, 1, 64-71 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 39, 1, 64-71 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 39, 1, 64-71 2016 公開
Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, Musashi Study Investigators. Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, Musashi Study Investigators. Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A, Musashi Study Investigators. Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. Arthritis care & research, 67, 10, 1354-1362 Arthritis care & research, 67, 10, 1354-1362 Arthritis care & research, 67, 10, 1354-1362 2015/10 公開
Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. BMC musculoskeletal disorders, 16, 129 BMC musculoskeletal disorders, 16, 129 BMC musculoskeletal disorders, 16, 129 2015/05 公開
Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis & rheumatology (Hoboken, N.J.), 67, 8, 2226-2232 Arthritis & rheumatology (Hoboken, N.J.), 67, 8, 2226-2232 Arthritis & rheumatology (Hoboken, N.J.), 67, 8, 2226-2232 2015/05 公開
Kono M, Miura N, Fujii T, Ohmura K, Yoshifuji H, Yukawa N, Imura Y, Nakashima R, Ikeda T, Umemura S, Miyatake T, Mimori T Kono M, Miura N, Fujii T, Ohmura K, Yoshifuji H, Yukawa N, Imura Y, Nakashima R, Ikeda T, Umemura S, Miyatake T, Mimori T Kono M, Miura N, Fujii T, Ohmura K, Yoshifuji H, Yukawa N, Imura Y, Nakashima R, Ikeda T, Umemura S, Miyatake T, Mimori T Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases--Possible Association with Vascular Disease and Seasonal Change. Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases--Possible Association with Vascular Disease and Seasonal Change. Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases--Possible Association with Vascular Disease and Seasonal Change. PloS one, 10, 12, e0144952 PloS one, 10, 12, e0144952 PloS one, 10, 12, e0144952 2015 公開
Yoshifuji H Yoshifuji H Yoshifuji H Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 9, Suppl 1, 141-146 Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 9, Suppl 1, 141-146 Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 9, Suppl 1, 141-146 2015 公開
Shiheido H, Kitagori K, Sasaki C, Kobayashi S, Aoyama T, Urata K, Oku T, Hirayama Y, Yoshitomi H, Hikida M, Yoshifuji H, Mimori T, Watanabe T, Shimizu J Shiheido H, Kitagori K, Sasaki C, Kobayashi S, Aoyama T, Urata K, Oku T, Hirayama Y, Yoshitomi H, Hikida M, Yoshifuji H, Mimori T, Watanabe T, Shimizu J Shiheido H, Kitagori K, Sasaki C, Kobayashi S, Aoyama T, Urata K, Oku T, Hirayama Y, Yoshitomi H, Hikida M, Yoshifuji H, Mimori T, Watanabe T, Shimizu J Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8. Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8. Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8. Immunity, inflammation and disease, 2, 1, 35-43 Immunity, inflammation and disease, 2, 1, 35-43 Immunity, inflammation and disease, 2, 1, 35-43 2014/06 公開
Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. Modern rheumatology, 24, 3, 464-470 Modern rheumatology, 24, 3, 464-470 Modern rheumatology, 24, 3, 464-470 2014/05 公開
C. Terao; H. Yoshifuji; T. Mimori C. Terao; H. Yoshifuji; T. Mimori C. Terao; H. Yoshifuji; T. Mimori Recent advances in Takayasu arteritis Recent advances in Takayasu arteritis Recent advances in Takayasu arteritis International Journal of Rheumatic Diseases, 17, 3, 238-247 International Journal of Rheumatic Diseases, 17, 3, 238-247 International Journal of Rheumatic Diseases, 17, 3, 238-247 2014/03 英語 公開
N. Yamakawa; M. Fujimoto; D. Kawabata; C. Terao; M. Nishikori; R. Nakashima; Y. Imura; N. Yukawa; H. Yoshifuji; K. Ohmura; T. Fujii; T. Kitano; T. Kondo; K. Yurugi; Y. Miura; T. Maekawa; H. Saji; A. Takaori-Kondo; F. Matsuda; H. Haga; T. Mimori N. Yamakawa; M. Fujimoto; D. Kawabata; C. Terao; M. Nishikori; R. Nakashima; Y. Imura; N. Yukawa; H. Yoshifuji; K. Ohmura; T. Fujii; T. Kitano; T. Kondo; K. Yurugi; Y. Miura; T. Maekawa; H. Saji; A. Takaori-Kondo; F. Matsuda; H. Haga; T. Mimori N. Yamakawa; M. Fujimoto; D. Kawabata; C. Terao; M. Nishikori; R. Nakashima; Y. Imura; N. Yukawa; H. Yoshifuji; K. Ohmura; T. Fujii; T. Kitano; T. Kondo; K. Yurugi; Y. Miura; T. Maekawa; H. Saji; A. Takaori-Kondo; F. Matsuda; H. Haga; T. Mimori A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders Journal of Rheumatology, 41, 2, 293-299 Journal of Rheumatology, 41, 2, 293-299 Journal of Rheumatology, 41, 2, 293-299 2014/02 英語 公開
K. Tanaka; C. Terao; K. Ohmura; M. Takahashi; R. Nakashima; Y. Imura; H. Yoshifuji; N. Yukawa; T. Usui; T. Fujii; T. Mimori; F. Matsuda K. Tanaka; C. Terao; K. Ohmura; M. Takahashi; R. Nakashima; Y. Imura; H. Yoshifuji; N. Yukawa; T. Usui; T. Fujii; T. Mimori; F. Matsuda K. Tanaka; C. Terao; K. Ohmura; M. Takahashi; R. Nakashima; Y. Imura; H. Yoshifuji; N. Yukawa; T. Usui; T. Fujii; T. Mimori; F. Matsuda Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases Journal of Human Genetics, 59, 2, 107-109 Journal of Human Genetics, 59, 2, 107-109 Journal of Human Genetics, 59, 2, 107-109 2014/02 英語 公開
Nakajima T, Kawabata D, Nakabo S, Miyagawa-Hayashino A, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Mimori T Nakajima T, Kawabata D, Nakabo S, Miyagawa-Hayashino A, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Mimori T Nakajima T, Kawabata D, Nakabo S, Miyagawa-Hayashino A, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Mimori T Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. Internal medicine (Tokyo, Japan), 53, 19, 2255-2258 Internal medicine (Tokyo, Japan), 53, 19, 2255-2258 Internal medicine (Tokyo, Japan), 53, 19, 2255-2258 2014 公開
Terao C, Yoshifuji H, Mimori T, Matsuda F Terao C, Yoshifuji H, Mimori T, Matsuda F Terao C, Yoshifuji H, Mimori T, Matsuda F [Susceptibility HLA alleles and amino acids to Takayasu arteritis]. [Susceptibility HLA alleles and amino acids to Takayasu arteritis]. [Susceptibility HLA alleles and amino acids to Takayasu arteritis]. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 3, 166-170 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 3, 166-170 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 3, 166-170 2014 公開
Terao C, Hashimoto M, Furu M, Nakabo S, Ohmura K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Matsuda F, Ito H, Fujii T, Mimori T Terao C, Hashimoto M, Furu M, Nakabo S, Ohmura K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Matsuda F, Ito H, Fujii T, Mimori T Terao C, Hashimoto M, Furu M, Nakabo S, Ohmura K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Matsuda F, Ito H, Fujii T, Mimori T Inverse association between air pressure and rheumatoid arthritis synovitis. Inverse association between air pressure and rheumatoid arthritis synovitis. Inverse association between air pressure and rheumatoid arthritis synovitis. PloS one, 9, 1, e85376 PloS one, 9, 1, e85376 PloS one, 9, 1, e85376 2014 公開
Yoshifuji H, Kinoshita H Yoshifuji H, Kinoshita H Yoshifuji H, Kinoshita H [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 6, 454-461 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 6, 454-461 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 37, 6, 454-461 2014 公開
Y. Kitai; K. Murakami; H. Yoshifuji; N. Yukawa; D. Kawabata; K. Ohmura; T. Fujii; T. Mimori Y. Kitai; K. Murakami; H. Yoshifuji; N. Yukawa; D. Kawabata; K. Ohmura; T. Fujii; T. Mimori Y. Kitai; K. Murakami; H. Yoshifuji; N. Yukawa; D. Kawabata; K. Ohmura; T. Fujii; T. Mimori A case of Behçet\\'s disease developing after poststreptococcal acute glomerulonephritis A case of Behçet\\'s disease developing after poststreptococcal acute glomerulonephritis A case of Behçet\\'s disease developing after poststreptococcal acute glomerulonephritis Modern Rheumatology, 23, 6, 1221-1225 Modern Rheumatology, 23, 6, 1221-1225 Modern Rheumatology, 23, 6, 1221-1225 2013/11 英語 公開
C. Terao; H. Yoshifuji; K. Ohmura; K. Murakami; D. Kawabata; K. Yurugi; J. Tazaki; H. Kinoshita; A. Kimura; M. Akizuki; Y. Kawaguchi; H. Yamanaka; Y. Miura; T. Maekawa; H. Saji; T. Mimori; F. Matsuda C. Terao; H. Yoshifuji; K. Ohmura; K. Murakami; D. Kawabata; K. Yurugi; J. Tazaki; H. Kinoshita; A. Kimura; M. Akizuki; Y. Kawaguchi; H. Yamanaka; Y. Miura; T. Maekawa; H. Saji; T. Mimori; F. Matsuda C. Terao; H. Yoshifuji; K. Ohmura; K. Murakami; D. Kawabata; K. Yurugi; J. Tazaki; H. Kinoshita; A. Kimura; M. Akizuki; Y. Kawaguchi; H. Yamanaka; Y. Miura; T. Maekawa; H. Saji; T. Mimori; F. Matsuda Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. Rheumatology (Oxford, England), 52, 10, 1769-1774 Rheumatology (Oxford, England), 52, 10, 1769-1774 Rheumatology (Oxford, England), 52, 10, 1769-1774 2013/10 英語 公開
C. Terao; H. Yoshifuji; A. Kimura; T. Matsumura; K. Ohmura; M. Takahashi; M. Shimizu; T. Kawaguchi; Z. Chen; T.K. Naruse; A. Sato-Otsubo; Y. Ebana; Y. Maejima; H. Kinoshita; K. Murakami; D. Kawabata; Y. Wada; I. Narita; J. Tazaki; Y. Kawaguchi; H. Yamanaka; K. Yurugi; Y. Miura; T. Maekawa; S. Ogawa; I. Komuro; R. Nagai; R. Yamada; Y. Tabara; M. Isobe; T. Mimori; F. Matsuda C. Terao; H. Yoshifuji; A. Kimura; T. Matsumura; K. Ohmura; M. Takahashi; M. Shimizu; T. Kawaguchi; Z. Chen; T.K. Naruse; A. Sato-Otsubo; Y. Ebana; Y. Maejima; H. Kinoshita; K. Murakami; D. Kawabata; Y. Wada; I. Narita; J. Tazaki; Y. Kawaguchi; H. Yamanaka; K. Yurugi; Y. Miura; T. Maekawa; S. Ogawa; I. Komuro; R. Nagai; R. Yamada; Y. Tabara; M. Isobe; T. Mimori; F. Matsuda C. Terao; H. Yoshifuji; A. Kimura; T. Matsumura; K. Ohmura; M. Takahashi; M. Shimizu; T. Kawaguchi; Z. Chen; T.K. Naruse; A. Sato-Otsubo; Y. Ebana; Y. Maejima; H. Kinoshita; K. Murakami; D. Kawabata; Y. Wada; I. Narita; J. Tazaki; Y. Kawaguchi; H. Yamanaka; K. Yurugi; Y. Miura; T. Maekawa; S. Ogawa; I. Komuro; R. Nagai; R. Yamada; Y. Tabara; M. Isobe; T. Mimori; F. Matsuda Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population American Journal of Human Genetics, 93, 2, 289-297 American Journal of Human Genetics, 93, 2, 289-297 American Journal of Human Genetics, 93, 2, 289-297 2013/08/08 英語 公開
H. Tsuji; H. Yoshifuji; R. Nakashima; Y. Imura; N. Yukawa; K. Ohmura; A. Miyagawa-Hayashino; K. Kabashima; T. Mimori H. Tsuji; H. Yoshifuji; R. Nakashima; Y. Imura; N. Yukawa; K. Ohmura; A. Miyagawa-Hayashino; K. Kabashima; T. Mimori H. Tsuji; H. Yoshifuji; R. Nakashima; Y. Imura; N. Yukawa; K. Ohmura; A. Miyagawa-Hayashino; K. Kabashima; T. Mimori Sweet\\'s syndrome associated with systemic lupus erythematosus: A case report and review of the literature Sweet\\'s syndrome associated with systemic lupus erythematosus: A case report and review of the literature Sweet\\'s syndrome associated with systemic lupus erythematosus: A case report and review of the literature Journal of Dermatology, 40, 8, 641-648 Journal of Dermatology, 40, 8, 641-648 Journal of Dermatology, 40, 8, 641-648 2013/08 英語 公開
C. Terao; M. Hashimoto; K. Yamamoto; K. Murakami; K. Ohmura; R. Nakashima; N. Yamakawa; H. Yoshifuji; N. Yukawa; D. Kawabata; T. Usui; H. Yoshitomi; M. Furu; R. Yamada; F. Matsuda; H. Ito; T. Fujii; T. Mimori C. Terao; M. Hashimoto; K. Yamamoto; K. Murakami; K. Ohmura; R. Nakashima; N. Yamakawa; H. Yoshifuji; N. Yukawa; D. Kawabata; T. Usui; H. Yoshitomi; M. Furu; R. Yamada; F. Matsuda; H. Ito; T. Fujii; T. Mimori C. Terao; M. Hashimoto; K. Yamamoto; K. Murakami; K. Ohmura; R. Nakashima; N. Yamakawa; H. Yoshifuji; N. Yukawa; D. Kawabata; T. Usui; H. Yoshitomi; M. Furu; R. Yamada; F. Matsuda; H. Ito; T. Fujii; T. Mimori Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database PLoS ONE, 8, 3, e59341 PLoS ONE, 8, 3, e59341 PLoS ONE, 8, 3, e59341 2013 英語 公開
M. Katayama; K. Ohmura; N. Yukawa; C. Terao; M. Hashimoto; H. Yoshifuji; D. Kawabata; T. Fujii; Y. Iwakura; T. Mimori M. Katayama; K. Ohmura; N. Yukawa; C. Terao; M. Hashimoto; H. Yoshifuji; D. Kawabata; T. Fujii; Y. Iwakura; T. Mimori M. Katayama; K. Ohmura; N. Yukawa; C. Terao; M. Hashimoto; H. Yoshifuji; D. Kawabata; T. Fujii; Y. Iwakura; T. Mimori Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis PLoS ONE, 8, 5, e62231 PLoS ONE, 8, 5, e62231 PLoS ONE, 8, 5, e62231 2013 英語 公開
Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 2013 公開
Y. Imura; Y. Shirai; T. Nojima; R. Nakashima; H. Yamagata; K. Miyachi; H. Yoshifuji; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; T. Mimori Y. Imura; Y. Shirai; T. Nojima; R. Nakashima; H. Yamagata; K. Miyachi; H. Yoshifuji; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; T. Mimori Y. Imura; Y. Shirai; T. Nojima; R. Nakashima; H. Yamagata; K. Miyachi; H. Yoshifuji; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; T. Mimori NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA Modern Rheumatology, 22, 5, 685-694 Modern Rheumatology, 22, 5, 685-694 Modern Rheumatology, 22, 5, 685-694 2012/09 英語 公開
K. Kiyama; D. Kawabata; Y. Hosono; K. Kitagori; N. Yukawa; H. Yoshifuji; K. Omura; T. Fujii; T. Mimori K. Kiyama; D. Kawabata; Y. Hosono; K. Kitagori; N. Yukawa; H. Yoshifuji; K. Omura; T. Fujii; T. Mimori K. Kiyama; D. Kawabata; Y. Hosono; K. Kitagori; N. Yukawa; H. Yoshifuji; K. Omura; T. Fujii; T. Mimori Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance Arthritis Research and Therapy, 14, 2, R86 Arthritis Research and Therapy, 14, 2, R86 Arthritis Research and Therapy, 14, 2, R86 2012/04 英語 公開
K. Murakami; M. Tanaka; T. Usui; D. Kawabata; A. Shiomi; M. Iguchi-Hashimoto; M. Shimizu; N. Yukawa; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; H. Umehara; T. Mimori K. Murakami; M. Tanaka; T. Usui; D. Kawabata; A. Shiomi; M. Iguchi-Hashimoto; M. Shimizu; N. Yukawa; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; H. Umehara; T. Mimori K. Murakami; M. Tanaka; T. Usui; D. Kawabata; A. Shiomi; M. Iguchi-Hashimoto; M. Shimizu; N. Yukawa; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; H. Umehara; T. Mimori Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4 Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4 Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4 FEBS Letters, 586, 4, 319-324 FEBS Letters, 586, 4, 319-324 FEBS Letters, 586, 4, 319-324 2012/02 英語 公開
M. Nakano; T. Fujii; M. Hashimoto; N. Yukawa; H. Yoshifuji; K. Ohmura; A. Nakaizumi; T. Mimori M. Nakano; T. Fujii; M. Hashimoto; N. Yukawa; H. Yoshifuji; K. Ohmura; A. Nakaizumi; T. Mimori M. Nakano; T. Fujii; M. Hashimoto; N. Yukawa; H. Yoshifuji; K. Ohmura; A. Nakaizumi; T. Mimori Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells Clinical and Experimental Immunology, 170, 1, 94-100 Clinical and Experimental Immunology, 170, 1, 94-100 Clinical and Experimental Immunology, 170, 1, 94-100 2012 英語 公開
J. Venkatesh; H. Yoshifuji; D. Kawabata; P. Chinnasamy; A. Stanevsky; C.M. Grimaldi; J. Cohen-Solal; B. Diamond J. Venkatesh; H. Yoshifuji; D. Kawabata; P. Chinnasamy; A. Stanevsky; C.M. Grimaldi; J. Cohen-Solal; B. Diamond J. Venkatesh; H. Yoshifuji; D. Kawabata; P. Chinnasamy; A. Stanevsky; C.M. Grimaldi; J. Cohen-Solal; B. Diamond Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation Journal of Immunology, 186, 9, 5304-5312 Journal of Immunology, 186, 9, 5304-5312 Journal of Immunology, 186, 9, 5304-5312 2011/05 英語 公開
M. Iguchi-Hashimoto; T. Usui; H. Yoshifuji; M. Shimizu; S. Kobayashi; Y. Ito; K. Murakami; A. Shiomi; N. Yukawa; D. Kawabata; T. Nojima; K. Ohmura; T. Fujii; T. Mimori M. Iguchi-Hashimoto; T. Usui; H. Yoshifuji; M. Shimizu; S. Kobayashi; Y. Ito; K. Murakami; A. Shiomi; N. Yukawa; D. Kawabata; T. Nojima; K. Ohmura; T. Fujii; T. Mimori M. Iguchi-Hashimoto; T. Usui; H. Yoshifuji; M. Shimizu; S. Kobayashi; Y. Ito; K. Murakami; A. Shiomi; N. Yukawa; D. Kawabata; T. Nojima; K. Ohmura; T. Fujii; T. Mimori Overexpression of a minimal domain of calpastatin suppresses il-6 production and th17 development via reduced nf-κb and increased stat5 signals Overexpression of a minimal domain of calpastatin suppresses il-6 production and th17 development via reduced nf-κb and increased stat5 signals Overexpression of a minimal domain of calpastatin suppresses il-6 production and th17 development via reduced nf-κb and increased stat5 signals PLoS ONE, 6, 10, e27020 PLoS ONE, 6, 10, e27020 PLoS ONE, 6, 10, e27020 2011 英語 公開
N. Yukawa; T. Fujii; S. Kondo-Ishikawa; H. Yoshifuji; D. Kawabata; T. Nojima; K. Ohmura; T. Usui; T. Mimori N. Yukawa; T. Fujii; S. Kondo-Ishikawa; H. Yoshifuji; D. Kawabata; T. Nojima; K. Ohmura; T. Usui; T. Mimori N. Yukawa; T. Fujii; S. Kondo-Ishikawa; H. Yoshifuji; D. Kawabata; T. Nojima; K. Ohmura; T. Usui; T. Mimori Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: A retrospective clinical study Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: A retrospective clinical study Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: A retrospective clinical study Arthritis Research and Therapy, 13, 6, R213 Arthritis Research and Therapy, 13, 6, R213 Arthritis Research and Therapy, 13, 6, R213 2011 英語 公開
Y. Ito; T. Usui; S. Kobayashi; M. Iguchi-Hashimoto; H. Ito; H. Yoshitomi; T. Nakamura; M. Shimizu; D. Kawabata; N. Yukawa; M. Hashimoto; N. Sakaguchi; S. Sakaguchi; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; T. Mimori Y. Ito; T. Usui; S. Kobayashi; M. Iguchi-Hashimoto; H. Ito; H. Yoshitomi; T. Nakamura; M. Shimizu; D. Kawabata; N. Yukawa; M. Hashimoto; N. Sakaguchi; S. Sakaguchi; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; T. Mimori Y. Ito; T. Usui; S. Kobayashi; M. Iguchi-Hashimoto; H. Ito; H. Yoshitomi; T. Nakamura; M. Shimizu; D. Kawabata; N. Yukawa; M. Hashimoto; N. Sakaguchi; S. Sakaguchi; H. Yoshifuji; T. Nojima; K. Ohmura; T. Fujii; T. Mimori Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis Arthritis and Rheumatism, 60, 8, 2294-2303 Arthritis and Rheumatism, 60, 8, 2294-2303 Arthritis and Rheumatism, 60, 8, 2294-2303 2009/08 英語 公開
R. Nakashima; Y. Imura; S. Kobayashi; N. Yukawa; H. Yoshifuji; T. Nojima; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; K. Okawa; T. Mimori R. Nakashima; Y. Imura; S. Kobayashi; N. Yukawa; H. Yoshifuji; T. Nojima; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; K. Okawa; T. Mimori R. Nakashima; Y. Imura; S. Kobayashi; N. Yukawa; H. Yoshifuji; T. Nojima; D. Kawabata; K. Ohmura; T. Usui; T. Fujii; K. Okawa; T. Mimori The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody Rheumatology, 49, 3, 433-440 Rheumatology, 49, 3, 433-440 Rheumatology, 49, 3, 433-440 2009 英語 公開
T. Mimori; Y. Imura; R. Nakashima; H. Yoshifuji T. Mimori; Y. Imura; R. Nakashima; H. Yoshifuji T. Mimori; Y. Imura; R. Nakashima; H. Yoshifuji Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance Current Opinion in Rheumatology, 19, 6, 523-529 Current Opinion in Rheumatology, 19, 6, 523-529 Current Opinion in Rheumatology, 19, 6, 523-529 2007/11 英語 公開
K. Murakami; T. Fujii; N. Yukawa; H. Yoshifuji; D. Kawabata; M. Tanaka; T. Usui; T. Mimori K. Murakami; T. Fujii; N. Yukawa; H. Yoshifuji; D. Kawabata; M. Tanaka; T. Usui; T. Mimori K. Murakami; T. Fujii; N. Yukawa; H. Yoshifuji; D. Kawabata; M. Tanaka; T. Usui; T. Mimori Successful treatment of a patient with refractory adult Still\\'s disease by tacrolimus Successful treatment of a patient with refractory adult Still\\'s disease by tacrolimus Successful treatment of a patient with refractory adult Still\\'s disease by tacrolimus Modern Rheumatology, 17, 2, 167-170 Modern Rheumatology, 17, 2, 167-170 Modern Rheumatology, 17, 2, 167-170 2007 英語 公開
Y. Ito; D. Kawabata; N. Yukawa; H. Yoshifuji; T. Usui; M. Tanaka; T. Fujii; T. Mimori Y. Ito; D. Kawabata; N. Yukawa; H. Yoshifuji; T. Usui; M. Tanaka; T. Fujii; T. Mimori Y. Ito; D. Kawabata; N. Yukawa; H. Yoshifuji; T. Usui; M. Tanaka; T. Fujii; T. Mimori Severe subcutaneous generalized edema in a patient with dermatomyositis Severe subcutaneous generalized edema in a patient with dermatomyositis Severe subcutaneous generalized edema in a patient with dermatomyositis Modern Rheumatology, 17, 2, 171-173 Modern Rheumatology, 17, 2, 171-173 Modern Rheumatology, 17, 2, 171-173 2007 英語 公開
S. Nakayamada; K. Saito; H. Umehara; N. Ogawa; T. Sumida; S. Ito; S. Minota; H. Nara; H. Kondo; J. Okada; T. Mimori; H. Yoshifuji; H. Sano; N. Hashimoto; S. Sugai; Y. Tanaka S. Nakayamada; K. Saito; H. Umehara; N. Ogawa; T. Sumida; S. Ito; S. Minota; H. Nara; H. Kondo; J. Okada; T. Mimori; H. Yoshifuji; H. Sano; N. Hashimoto; S. Sugai; Y. Tanaka S. Nakayamada; K. Saito; H. Umehara; N. Ogawa; T. Sumida; S. Ito; S. Minota; H. Nara; H. Kondo; J. Okada; T. Mimori; H. Yoshifuji; H. Sano; N. Hashimoto; S. Sugai; Y. Tanaka Efficacy and safety of mizoribine for the treatment of Sjögren\\'s syndrome: A multicenter open-label clinical trial Efficacy and safety of mizoribine for the treatment of Sjögren\\'s syndrome: A multicenter open-label clinical trial Efficacy and safety of mizoribine for the treatment of Sjögren\\'s syndrome: A multicenter open-label clinical trial Modern Rheumatology, 17, 6, 464-469 Modern Rheumatology, 17, 6, 464-469 Modern Rheumatology, 17, 6, 464-469 2007 英語 公開
H. Yoshifuji; T. Fujii; S. Kobayashi; Y. Imura; Y. Fujita; D. Kawabata; T. Usui; M. Tanaka; S. Nagai; H. Umehara; T. Mimori H. Yoshifuji; T. Fujii; S. Kobayashi; Y. Imura; Y. Fujita; D. Kawabata; T. Usui; M. Tanaka; S. Nagai; H. Umehara; T. Mimori H. Yoshifuji; T. Fujii; S. Kobayashi; Y. Imura; Y. Fujita; D. Kawabata; T. Usui; M. Tanaka; S. Nagai; H. Umehara; T. Mimori Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies Autoimmunity, 39, 3, 233-241 Autoimmunity, 39, 3, 233-241 Autoimmunity, 39, 3, 233-241 2006/05 英語 公開
H. Yoshifuji; H. Umehara; H. Maruyama; M. Itoh; M. Tanaka; D. Kawabata; T. Fujii; T. Mimori H. Yoshifuji; H. Umehara; H. Maruyama; M. Itoh; M. Tanaka; D. Kawabata; T. Fujii; T. Mimori H. Yoshifuji; H. Umehara; H. Maruyama; M. Itoh; M. Tanaka; D. Kawabata; T. Fujii; T. Mimori Amelioration of experimental arthritis by a calpain-inhibitory compound: Regulation of cytokine production by E-64-d in vivo and in vitro Amelioration of experimental arthritis by a calpain-inhibitory compound: Regulation of cytokine production by E-64-d in vivo and in vitro Amelioration of experimental arthritis by a calpain-inhibitory compound: Regulation of cytokine production by E-64-d in vivo and in vitro International Immunology, 17, 10, 1327-1336 International Immunology, 17, 10, 1327-1336 International Immunology, 17, 10, 1327-1336 2005 英語 公開
M. Hashimoto; H. Yoshifuji; T. Mimori M. Hashimoto; H. Yoshifuji; T. Mimori Hashimoto M, Yoshifuji H, Mimori T A case of dermatomyositis associated with different types of cancers at intervals of six years A case of dermatomyositis associated with different types of cancers at intervals of six years [A case of dermatomyositis associated with different types of cancers at intervals of six years]. Nihon Rinsho Men\\'eki Gakkai kaishi = Japanese journal of clinical immunology, 27, 6, 427-430 Nihon Rinsho Men\\'eki Gakkai kaishi = Japanese journal of clinical immunology, 27, 6, 427-430 Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 27, 6, 427-430 2004/12 日本語 公開
D. Kawabata; M. Tanaka; T. Fujii; H. Umehara; Y. Fujita; H. Yoshifuji; T. Mimori; S. Ozaki D. Kawabata; M. Tanaka; T. Fujii; H. Umehara; Y. Fujita; H. Yoshifuji; T. Mimori; S. Ozaki D. Kawabata; M. Tanaka; T. Fujii; H. Umehara; Y. Fujita; H. Yoshifuji; T. Mimori; S. Ozaki Ameliorative Effects of Follistatin-Related Protein/TSC-36/FSTL1 on Joint Inflammation in a Mouse Model of Arthritis Ameliorative Effects of Follistatin-Related Protein/TSC-36/FSTL1 on Joint Inflammation in a Mouse Model of Arthritis Ameliorative Effects of Follistatin-Related Protein/TSC-36/FSTL1 on Joint Inflammation in a Mouse Model of Arthritis Arthritis and Rheumatism, 50, 2, 660-668 Arthritis and Rheumatism, 50, 2, 660-668 Arthritis and Rheumatism, 50, 2, 660-668 2004/02 英語 公開

  • <<
  • >>
  • 表示
タイトル言語:
Misc
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. Int Immunol, 17(10):1327-36 Int Immunol, 17(10):1327-36 , 17(10):1327-36 2005 公開
Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. Int Immunol, 17(10):1327-36 , 17(10):1327-36 Int Immunol, 17(10):1327-36 2005 公開
タイトル言語:
外部資金:競争的資金・科学研究費補助金
種別 代表/分担 テーマ(日本語) テーマ(英語) 期間
基盤研究(C) 代表 腎炎発症モデル抗DNA抗体遺伝子ノックイン・マウスへの特異的治療アプローチ 2013〜2015
基盤研究(C) 代表 腎炎発症モデル抗DNA抗体遺伝子ノックイン・マウスへの特異的治療アプローチ (平成26年度分) 2014/04/01〜2015/03/31
基盤研究(C) 代表 腎炎発症モデル抗DNA抗体遺伝子ノックイン・マウスへの特異的治療アプローチ (平成27年度分) 2015/04/01〜2016/03/31
難治性疾患等政策研究事業(難治性疾患政策研究事業) 分担 (平成27年度分) 2015/04/01〜2016/03/31
難治性疾患等政策研究事業(難治性疾患政策研究事業) 分担 (平成28年度分) 2016/04/01〜2017/03/31
基盤研究(C) 代表 高安動脈炎の病因解明と治療法改良への遺伝子研究成果からのアプローチ (平成29年度分) 2017/04/01〜2018/03/31
難治性疾患等政策研究事業(難治性疾患政策研究事業) 分担 (平成29年度分) 2017/04/01〜2018/03/31
難治性疾患等政策研究事業(難治性疾患政策研究事業) 分担 (平成30年度分) 2018/04/01〜2019/03/31
基盤研究(C) 代表 高安動脈炎の病因解明と治療法改良への遺伝子研究成果からのアプローチ (平成30年度分) 2018/04/01〜2019/03/31
外部資金:競争的資金・科学研究費補助金以外
制度名 代表者名 研究課題(日本語) 研究課題(英語) 期間
多発性筋炎・皮膚筋炎の分類法,治療反応性・予後予測法の改良 Innovation on classification of polymyositis/dermatomyositis, Innovation on prediction of treatment-sensitivity and prognosis of myositis and interstitial pneumonitis complicated with polymyositis/dermatomyositis 2002〜
部局運営(役職等)
役職名 期間
外来医長・看護師長会議・委員 2013/04/01〜